Prior exercise protects against oxidative stress and motor deficit in a rat model of Parkinson's disease

Metab Brain Dis. 2020 Jan;35(1):175-181. doi: 10.1007/s11011-019-00507-z. Epub 2019 Nov 28.

Abstract

This study investigated if a prior long-term physical exercise protocol protects the substantia nigra and the striatum against oxidative stress and motor deficits in a Parkinson Disease model induced by 6-hydroxydopamine. Three animal treatment groups were included in the study: sham; 6-hydroxydopamine and 6-hydroxydopamine/exercise. Previously to the intrastriatal lesion by 6-hydroxydopamine, rats in the exercise groups performed a swimming program for 18 weeks. The rats were submitted to behavioral tests before and after intrastriatal 6-hydroxydopamine injection. The oxidative stress was analyzed by Thiobarbituric Acid Reactive Substances and Glutathione reductase activity methods. The exercise decreased lipid peroxidation and increased glutathione reductase activity in the substantia nigra. In contrast, in the striatum, exercise increased lipid peroxidation and decreased glutathione reductase activity. Exercise increased contralateral rotations and reduces immobility levels at 14 days post lesion. The exercise prior to 6-OHDA lesion had protective action only in substantia nigra against oxidative stress.

Keywords: Exercise therapy; Movement disorders; Oxidative stress; Parkinson disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Male
  • Motor Skills Disorders / chemically induced
  • Motor Skills Disorders / metabolism*
  • Motor Skills Disorders / prevention & control*
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology*
  • Oxidopamine / toxicity*
  • Parkinsonian Disorders / chemically induced
  • Parkinsonian Disorders / metabolism*
  • Parkinsonian Disorders / prevention & control*
  • Physical Conditioning, Animal / methods
  • Physical Conditioning, Animal / physiology*
  • Random Allocation
  • Rats
  • Rats, Wistar

Substances

  • Oxidopamine